Carly Helfand
@CarlyHFierce
Executive editor of @FiercePharma and @FierceBiotech; Chicago native; intent traveler; hockey fan; Irish fiddler; comma police.
233 Following 2.9K Followers
Today's roundup of #JPM19# news: JPM need-to-know, Part 2: GSK's cancer convictions; Amgen's diverse defense; GW's ambitions and more
